BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30526722)

  • 1. HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism.
    Martin S; Colle R; El Asmar K; Rigal A; Vievard A; Feve B; Becquemont L; Verstuyft C; Corruble E
    Psychol Med; 2019 Oct; 49(14):2364-2369. PubMed ID: 30526722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.
    Colle R; Gressier F; Verstuyft C; Deflesselle E; Lépine JP; Ferreri F; Hardy P; Guilloux JP; Petit AC; Fève B; Falissard B; Becquemont L; Corruble E
    J Affect Disord; 2015 Apr; 175():233-40. PubMed ID: 25658497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder.
    Zou YF; Ye DQ; Feng XL; Su H; Pan FM; Liao FF
    Eur Neuropsychopharmacol; 2010 Aug; 20(8):535-44. PubMed ID: 20167454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.
    Verhagen M; van der Meij A; van Deurzen PA; Janzing JG; Arias-Vásquez A; Buitelaar JK; Franke B
    Mol Psychiatry; 2010 Mar; 15(3):260-71. PubMed ID: 18852698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.
    Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
    Hum Psychopharmacol; 2010 Mar; 25(2):145-52. PubMed ID: 20196181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.
    Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
    Neuropsychobiology; 2010; 61(2):71-8. PubMed ID: 20016225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.
    Colle R; Trabado S; David DJ; Brailly-Tabard S; Hardy P; Falissard B; Fève B; Becquemont L; Verstuyft C; Corruble E
    Neuropsychobiology; 2017; 75(1):39-45. PubMed ID: 28848102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
    Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
    Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy.
    Pathak P; Mehra A; Ram S; Pal A; Grover S
    Behav Brain Res; 2022 Jul; 430():113931. PubMed ID: 35605794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype.
    Carballedo A; Amico F; Ugwu I; Fagan AJ; Fahey C; Morris D; Meaney JF; Leemans A; Frodl T
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jul; 159B(5):537-48. PubMed ID: 22585743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.
    Alexopoulos GS; Glatt CE; Hoptman MJ; Kanellopoulos D; Murphy CF; Kelly RE; Morimoto SS; Lim KO; Gunning FM
    J Affect Disord; 2010 Sep; 125(1-3):262-8. PubMed ID: 20346518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population.
    Suchanek R; Owczarek A; Kowalczyk M; Kucia K; Kowalski J
    J Mol Neurosci; 2011 Mar; 43(3):524-30. PubMed ID: 21103954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in brain-derived neurotrophic factor val66met allele is associated with altered serotonin-1A receptor binding in human brain.
    Lan MJ; Ogden RT; Huang YY; Oquendo MA; Sullivan GM; Miller J; Milak M; Mann JJ; Parsey RV
    Neuroimage; 2014 Jul; 94():33-39. PubMed ID: 24607934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).
    Katsuki A; Yoshimura R; Kishi T; Hori H; Umene-Nakano W; Ikenouchi-Sugita A; Hayashi K; Atake K; Iwata N; Nakamura J
    CNS Spectr; 2012 Sep; 17(3):155-63. PubMed ID: 22883353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression.
    Kanellopoulos D; Gunning FM; Morimoto SS; Hoptman MJ; Murphy CF; Kelly RE; Glatt C; Lim KO; Alexopoulos GS
    Am J Geriatr Psychiatry; 2011 Jan; 19(1):13-22. PubMed ID: 21218562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.
    Cao B; Bauer IE; Sharma AN; Mwangi B; Frazier T; Lavagnino L; Zunta-Soares GB; Walss-Bass C; Glahn DC; Kapczinski F; Nielsen DA; Soares JC
    J Affect Disord; 2016 Jul; 198():198-205. PubMed ID: 27018938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis.
    Yan T; Wang L; Kuang W; Xu J; Li S; Chen J; Yang Y
    Asia Pac Psychiatry; 2014 Sep; 6(3):241-51. PubMed ID: 25231750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression.
    Hennings JM; Kohli MA; Uhr M; Holsboer F; Ising M; Lucae S
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109686. PubMed ID: 31295515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression.
    Caldieraro MA; McKee M; Leistner-Segal S; Vares EA; Kubaski F; Spanemberg L; Brusius-Facchin AC; Fleck MP; Mischoulon D
    World J Biol Psychiatry; 2018 Aug; 19(5):402-409. PubMed ID: 28656803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.